about
Exercise-based cardiac rehabilitation for adults after heart valve surgeryExercise-based cardiac rehabilitation for adults after heart valve surgeryVarying effects of recommended treatments for heart failure with reduced ejection fraction: meta-analysis of randomized controlled trials in the ESC and ACCF/AHA guidelinesDiffering prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysisThe immediate future for the medical treatment of atrial fibrillationEffects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic reviewGeographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trialRelation between renal dysfunction and cardiovascular outcomes after myocardial infarctionESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with theIncreased mortality after dronedarone therapy for severe heart failureRelation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effectsEffect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac EvaluationDofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study GroupCause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide studyEchocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathyLong-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-conveNon-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.Renal dysfunction, restrictive left ventricular filling pattern and mortality risk in patients admitted with heart failure: a 7-year follow-up studyShort-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data.Identifying Drug-Drug Interactions by Data Mining: A Pilot Study of Warfarin-Associated Drug Interactions.Qt dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function.Arrhythmic and sudden death in chronic ischemic heart disease--a review of epidemiological data.Long-term outcome of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: a Scandinavian multicenter study.The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish nationwide study.Accuracy of the ICD-10 discharge diagnosis for syncope.Comparative cardiovascular safety of dementia medications: a cross-national study.Prognosis among healthy individuals discharged with a primary diagnosis of syncope.Comparison of incidence, predictors, and the impact of co-morbidity and polypharmacy on the risk of recurrent syncope in patients <85 versus ≥85 years of age.Incidence and influence of hospitalization for recurrent syncope and its effect on short- and long-term all-cause and cardiovascular mortality.Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data.Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarction among 11 680 patients with myocardial infarction treated with percutaneous coronary intervention: a cohort studyThe weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period.Risk prediction of cardiovascular death based on the QTc interval: evaluating age and gender differences in a large primary care populationIngestion of broccoli sprouts does not improve endothelial function in humans with hypertension.Increased susceptibility to cardiovascular effects of dihydrocapcaicin in resuscitated rats. Cardiovascular effects of dihydrocapsaicinSpontaneous coronary artery dissection. Case report and literature review.Drug-induced mild therapeutic hypothermia obtained by administration of a transient receptor potential vanilloid type 1 agonist.Risk stratification in emergency patients by copeptinAge-distribution, risk factors and mortality in smokers and non-smokers with acute myocardial infarction: a review. TRACE study group. Danish Trandolapril Cardiac Evaluation.
P50
Q24186018-82C53486-1FB4-4D4D-B74E-562F7CF59CE9Q24202163-91272550-6562-41E0-B9F4-40D795C47DE9Q28069387-0CF3AA51-180C-45D3-BCF9-52533C2E62D0Q28085643-1EA18953-CBFB-4D46-AEC8-8CAB13684E07Q28182304-D38EC6A7-CE70-4E18-A40B-E5AA059424C1Q28193960-D23AE912-D4AE-4A79-A959-1F066AC23AFFQ28200209-BDCF97A0-754F-461D-9194-BEB0706DE85BQ28213597-5BC8071A-E595-4D5E-BCC9-54F1708A1BD3Q28267062-CBBC821F-04BC-440F-843C-AF7AD2C3DE1CQ28284464-7265A225-ABE0-4F14-8C62-06CFDC58F839Q28335101-9CD7AED1-1AAF-48BB-A8C7-3870A1CF92EAQ28369201-9145B40C-6041-4EA0-8E82-03DDB27655C6Q28372836-EDE46485-943D-4BC1-958A-9E2BA3304524Q28485380-BDB6BB24-F152-491B-B315-EE6FE07A9BC9Q30480164-3DC1FED2-364E-4509-A65A-B81D2A454067Q30596519-D369BF42-BF0D-44FF-8A09-B8541C94D06DQ30597068-B4F18C1F-3EA6-4754-8C99-EFE05086988FQ30853679-BF7C9B86-8EC2-4B31-9305-C28DCA49F959Q31145367-0D7E510D-C526-48A3-B2B3-E6D7DD2BA4FAQ31159433-0723B19E-84EF-4EBF-A35C-4B8040845AF7Q31171225-ACFF80C1-D344-4A85-8DC0-AD646ADDB93EQ31920864-28C184CC-EDBC-4D8E-A4AD-251251EFBD34Q32100377-5FB33C09-D0A5-4BB6-99C4-2FF034654308Q33160002-75BAC80D-5E55-4DBF-89D2-4B63C3FF62ADQ33161294-DF69DE46-2091-40D2-94D7-407F2356DBCBQ33161992-A9634525-2AA2-444C-8D57-C8F7F661CA24Q33162060-6CEC0AE3-1A1A-40BD-949D-80A75D0FB9F5Q33162159-9C12406D-6586-46CD-8C49-626369F557E0Q33163274-0EBC62B8-521E-4CC0-9AB1-8EC9A0FA1F66Q33164069-6FB4B80A-2F6A-4132-9026-D40303ED4F2AQ33518180-0BFD35DF-E0F6-4EE5-8320-B3A6E64F138EQ33527547-F82DF898-B1F4-4F66-BAB9-E160F84BFB9FQ33534537-EF21A871-AD66-4D7B-BE41-97B1DE7508A1Q33639975-D77645A1-0D19-49AA-8969-190A647A4A4BQ33678871-7861DF05-E439-4F7D-9C66-9E5993771AFFQ33679466-F11126B8-C687-4100-A166-045195D91F38Q33683922-51E14336-0D5B-4B63-A518-18BB5979C046Q33713377-94F29C64-360B-4370-AE94-666F81348D30Q33740059-E7A83F21-BB60-49C9-BDBD-80C2ECBFA28EQ33759334-4C1FAFA5-FDFC-4E99-AE9B-D6EAE72BF817
P50
description
onderzoeker
@nl
name
Lars Køber
@ast
Lars Køber
@en
Lars Køber
@es
Lars Køber
@nl
Lars Køber
@sl
type
label
Lars Køber
@ast
Lars Køber
@en
Lars Køber
@es
Lars Køber
@nl
Lars Køber
@sl
prefLabel
Lars Køber
@ast
Lars Køber
@en
Lars Køber
@es
Lars Køber
@nl
Lars Køber
@sl
P214
P106
P108
P21
P214
P31
P735
P7859
viaf-268858761